We’re ready for the Vit Buckle Society #VBS2025 Annual Meeting in Austin. We are looking forward to connecting with #VitreoretinalSurgeons and professionals on advancing the #Retina field.?? ? Stop by our medical booth to learn more about #EYPT!?
EyePoint Pharmaceuticals
生物技术研究
Watertown，MA 14,443 位关注者
Delivering Innovation to the Eye? NOW HIRING!
关于我们
EyePoint Pharmaceuticals (Nasdaq: EYPT) is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company's pipeline leverages its proprietary Durasert? technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert’s proven intravitreal drug delivery platform has been safely administered to thousands of patients' eyes across four U.S. FDA-approved products, including YUTIQ? for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.
- 网站
-
https://www.eyepointpharma.com
EyePoint Pharmaceuticals的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Watertown，MA
- 类型
- 上市公司
- 领域
- Ophthalmology、Glaucoma、WetAMD、Optometry、Eye Disease和Retinal Disease
地点
-
获取路线
480 Pleasant St., Suite B300
US，MA，Watertown，02472
EyePoint Pharmaceuticals员工
动态
-
#EYPT is heading back from Miami after a productive few days at the Leerink Partners & Barclays Global Healthcare Conferences. We enjoyed sharing more about our innovative #RetinaPipeline with the investor community.?
-
-
We are a proud partner of The Carroll Center for the Blind and are honored to contribute to their mission of helping people who are blind or visually impaired gain skills to be confident, active, independent individuals. We look forward to getting our steps in at their upcoming Walk for Independence!
??Thank you to our Walk for Independence Gold Sponsor: EyePoint Pharmaceuticals!?? We are incredibly grateful for EyePoint Pharmaceuticals' generous support of The Carroll Center for the Blind in this year’s Walk for Independence! This winter, EyePoint also volunteered to spread holiday cheer by helping our clients decorate gingerbread houses, furthering their commitment to supporting our mission. EyePoint Pharmaceuticals is dedicated to developing life-changing therapies for individuals with serious retinal diseases. Their passion for improving patients’ lives, coupled with their generosity, makes a profound impact in the healthcare industry and our community. We truly appreciate their partnership and support in furthering our mission? To learn more about their work, visit their website at www.eyepointpharma.com Join us for the Walk for Independence! ?? Saturday, May 31, 2025 | 9:00 A.M. – 12:00 P.M. ET ?? Mount Ida Campus of UMass Amherst – 100 Carlson Ave, Newton, MA Learn more and register: carroll.org/walk #WalkForIndependence #SponsorSpotlight #MakingADifference #GivingBack #CommunitySupport #WalkForACause
-
-
Last week, our #EYPT team attended the RCA Research National Meeting in Aurora, CO, to share more about our pivotal Ph3 #LUGANO and #LUCIA #WetAMD clinical trials.??? ? Thank you to everyone who stopped by to connect and learn about our clinical progress.?? ? #InvestorNews?
-
-
$EYPT is in #Miami for the Barclays Global Healthcare Conference, where President & CEO Jay S. Duker, M.D. will be speaking at a Fireside chat. Looking forward to sharing our recent progress on our #RetinaPipeline with the investor community. See you there!? ? #InvestorNews??
-
-
#EYPT is at this week’s Leerink Partners Global Healthcare Conference. President & CEO Jay S. Duker, M.D. will be presenting on our innovative #RetinaPipeline and commitment to improving the lives of patients with serious #RetinalDiseases.? We hope to see you there!??
-
-
At our recent meeting in San Antonio, TX, we heard firsthand perspectives from #StudyCoordinators who are working on our pivotal Phase 3 #LUGANO and #LUCIA #WetAMD clinical trials. They shared insights on their work overseeing daily clinical trial activities, managing schedules and the enrollment process, and much more. #ThankYou to all who participated. We appreciate your contributions as we work to potentially reduce treatment burden and revolutionize outcomes for patients. ·??????Mary Jo Doran, Retina Associates of Western NY ·??????Courtney Smith, Research Institute of Texas ·??????Rachel McCullough, Texas Retina Associates ·??????Andrea Lopez, Center of Northern Colorado ·??????Michelle Schutt, Retina Associates ·?Joshua Watson, Bay Area Retina Associates Learn more on our website: https://lnkd.in/eN4BpBGi
-
-
This #InternationalWomensDay we celebrate the women who make up the EyePoint team! EyePoint is proud to support organizations like Women in Ophthalmology and ASRS – American Society of Retina Specialists’ Women in Retina, who are paving the way for future women leaders in #Ophthalmology.?? ? #AccelerateAction #IWD2025?
-
-
We are excited to be in #Spain for the 28th Congress of the Spanish Society of Retina and Vitreous (SERV).?? ? Attending? Join Doctor I?igo Corcóstegui, Medical Director at Miranza Clínica Bego?a, as he presents the results from the #DAVIO2 #WetAMD clinical trial.??
-